Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) announced it received a notice from the Nasdaq Capital Market regarding non-compliance with listing rules due to the company’s failure to hold its ...
Coeptis Therapeutics Holdings was hit with a shareholder lawsuit on Jan. 9 in New York Supreme Court for New York County over the company's proposed $835 million merger with Z Squared. The suit, ...
The MarketWatch News Department was not involved in the creation of this content. BRISTOL, TN / ACCESS Newswire / January 6, 2026 / The Vanderbilt Report today published coverage of Coeptis ...
WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, , announced today ...
BRISTOL, TN / ACCESS Newswire / October 1, 2025 / Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) today announced that The Vanderbilt Report has published coverage of the company following its ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min CEO of Wexford company talks ...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 1% on Friday. The Dow traded down 0.17% to 40,024.00 while the NASDAQ rose 0.96% to 17,330.36. The S&P 500 ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) and Z Squared Inc. is fair to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Coeptis is expanding its cancer ...
COEPTIS, Inc. has announced a strategic partnership with its NexGenAI Affiliates Network and NUBURU, Inc. This collaboration aims to enhance NUBURU's Transformation Plan, which focuses on improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results